Sinopharm (01099): China National Pharmaceutical Group's operating profit in the first three quarters was 962 million yuan, a year-on-year decrease of 10.34%.
China National Pharmaceutical Group Corporation (01099) announced that its subsidiary, China Medical Equipment Co., Ltd. (China National Pharmaceutical Equipment), as of...
Sinopharm (01099) announced that its subsidiary, China Medical Device Co., Ltd. (Sinopharm Medical Device), achieved operating income of RMB 54.693 billion for the nine months ended September 30, 2025, a decrease of 2.41% year-on-year; operating profit was RMB 0.962 billion, down by 10.34% year-on-year; total comprehensive income attributable to owners of the parent company was RMB 0.395 billion, down by 2.71% year-on-year.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
